BCL2 and neoplasm: Furthermore, miR-34a encapsulated in chitosan/PLGA nanoparticles inhibited tumor growth in murine xenograft models of human multiple myeloma disease since this miRNA directly downregulates proteins associated with tumor development, i.e., Bcl-2, Notch 1, and CDK6 [151].